ARTICLE | Company News
Cyclacel to screen library for CVTX
December 5, 2000 8:00 AM UTC
Cancer company Cyclacel (Dundee, Scotland) will screen a library of small molecule compounds developed by CV Therapeutics to determine their potential to inhibit the cancer cell cycle. Cyclacel has th...